Hedy Kindler to Poly(ADP-ribose) Polymerase Inhibitors
This is a "connection" page, showing publications Hedy Kindler has written about Poly(ADP-ribose) Polymerase Inhibitors.
Connection Strength
0.847
-
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib. Ann Oncol. 2019 12 01; 30(12):1959-1968.
Score: 0.696
-
Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma. Eur J Cancer. 2018 01; 89:19-26.
Score: 0.152